Trial Information

Summary: Is your tendonitis or bursitis pain keeping you out of the game?

If you suffer with moderate to severe pain of the elbow, knee, or shoulder, you may have tendonitis or bursitis. Tendonitis is an inflammation or irritation of the tendon; most often caused by repetitive, minor impact on the affected area. Bursitis is an inflammation or irritation of the bursa. The bursa is a sac filled with fluid that helps decrease friction and irritation between tissues.

Clinical Research Center of Cape Cod, Inc is currently enrolling adults who suffer with tendonitis or bursitis of the shoulder, elbow, or knee. This study is evaluating the safety and effectiveness of an investigational patch for the relief of pain associated with these conditions.

Qualified study participants may receive study supervision by a board-certified physician, study-related tests and exams, as well as study medication at no charge. In addition, qualified participants will receive compensation for their time and travel.

Eligibility Criteria:

  • Are you at least 18 years of age?
  • Do you suffer with tendonitis or bursitis of the shoulder, elbow, or knee?

If you answered yes to the previous questions, you may qualify to participate. For more information,

Contact:

James McCarthy
Clinical Research Center of Cape Cod, Inc (formerly Cape Cod Clinical Trials, Inc)
134 Ansel Hallet Road
West Yarmouth, MA 02673
Telephone: 508-778-1339

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:29:58 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA